The development of pneumonia in lymphoma patients may be associated with the application of rituximab and cytotoxic drugs (such as cyclophosphamide, doxorubicin, epirubicin, and PD-1) and mixed infections due to agranulocytosis. Here, PDCD1 is linked to Absence of circulating granulocytes.